Celecoxib in Treating Patients With Bladder Cancer

Clinical trial NCT00006124 · COMPLETED

Trial details

NCT number: NCT00006124
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Recurrent Bladder Cancer

Start date: 2000-06-01
Primary completion: 2006-03-01
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.